Anzeige
Meldung des Tages: Early Bird Special: Ad-hoc im Schatten einer milliardenschweren Entscheidung

Spyre Therapeutics News

Aktie
WKN:  A3D4LY ISIN:  US00773J2024 US-Symbol:  SYRE Branche:  Biotechnologie Land:  USA
69,37 $
-5,08 $
-6,82%
59,185 € 01.05.26
Depot/Watchlist
Marktkapitalisierung *
1,01 Mrd. €
Streubesitz
9,00%
KGV
-15,43
Index-Zuordnung
-

Spyre Therapeutics News

17.06.25 - PR Newswire
Spyre Therapeutics Announces Positive Interim Phase 1 Results for Two Next-Generation TL1A Antibody Programs, and Provides Clinical Development Updates Expected to Deliver 9 Phase 2 Readouts
Spyre Therapeutics Announces Positive Interim Phase 1 Results for Two Next-​Generation TL1A Antibody Programs, and Provides Clinical Development Updates Expected to Deliver ...
16.06.25 - PR Newswire
Spyre Therapeutics to Host Conference Call and Webcast to Report Interim Results from Phase 1 Healthy Volunteer Trials for its SPY002 Program, its Novel Half-Life Extended Anti-TL1A Antibodies on June 17, 2025
Spyre Therapeutics to Host Conference Call and Webcast to Report Interim Results from Phase 1 Healthy Volunteer Trials for its SPY002 Program, its Novel Half-Life Extended Anti-...
06.06.25 - PR Newswire
Spyre Therapeutics Announces Grants of Inducement Awards
Spyre Therapeutics Announces Grants of Inducement Awards PR Newswire
28.05.25 - PR Newswire
Spyre Therapeutics to Participate in Upcoming June Investor Conferences
Spyre Therapeutics to Participate in Upcoming June Investor Conferences PR Newswire
08.05.25 - PR Newswire
Spyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
Spyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update PR Newswire
05.05.25 - PR Newswire
Spyre Therapeutics Announces Poster Presentations at Digestive Disease Week (DDW) 2025 Including Up to Eight months of Follow-up from an Ongoing Phase 1 Trial of SPY001
Spyre Therapeutics Announces Poster Presentations at Digestive Disease Week (DDW) 2025 Including Up to Eight months of Follow-up from an Ongoing Phase 1 Trial of SPY001 ...

Newssuche

Videos

newspaper
26.04.26
Big Fish Strategy Einführung
Strategie-​Paket inklusive Live-​Webinar am 3.5., Videoaufzeichnung, Unterlagen und Nachbetreuung JETZT ... Mehr »
Anzeige

Aktie im Fokus

Mit Graphen gegen jede Abwehr
Plaid Technologies
0,396 €
+7,03%
Plaid Technologies Chart
Die Zukunft der Drohnen ist da
Mehr zur Aktie »